Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill M Siegfried

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Seminars in Oncology|December 10, 2009
Estrogen receptor signaling in lung cancerJill M Siegfried, Pamela A Hershberger, Laura P Stabile
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patientsWilliam L Bigbee, Jennifer R Grandis, Jill M Siegfried
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2020
Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy InhibitorChristian Njatcha, Mariya Farooqui, Abdulaziz A Almotlak, et al.
Current Angiogenesis|February 10, 2021
HGF Airway Over-expression Leads to Enhanced Pulmonary Vascularization without Induction of VEGFCassandra Henry, Ariel Lopez-Chavez, Laura P Stabile, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patientsYang Liu, Qing Lan, Jill M Siegfried, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
No association between the XPD 312, 751, or XRCC1 399 polymorphisms and K-ras gene mutation in smoking non-small-cell lung cancerWei-Min Gao, Marjorie Romkes, Jill M Siegfried, et al.
Medical Physics|August 17, 2012
Illustration of the obstacles in computerized lung segmentation using examplesXin Meng, Yongqian Qiang, Shaocheng Zhu, et al.
Molecular Carcinogenesis|July 26, 2006
Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokersWei-Min Gao, Marjorie Romkes, Jill M Siegfried, et al.
Oncotarget|April 28, 2017
Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancerJill M Siegfried, Mariya Farooqui, Natalie J Rothenberger, et al.
Chest|May 12, 2004
Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lungJill M Siegfried, James D Luketich, Laura P Stabile, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Oncology|December 10, 2009
Estrogen receptor signaling in lung cancerJill M Siegfried, Pamela A Hershberger, Laura P Stabile
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patientsWilliam L Bigbee, Jennifer R Grandis, Jill M Siegfried
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2020
Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy InhibitorChristian Njatcha, Mariya Farooqui, Abdulaziz A Almotlak, et al.
Current Angiogenesis|February 10, 2021
HGF Airway Over-expression Leads to Enhanced Pulmonary Vascularization without Induction of VEGFCassandra Henry, Ariel Lopez-Chavez, Laura P Stabile, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patientsYang Liu, Qing Lan, Jill M Siegfried, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
No association between the XPD 312, 751, or XRCC1 399 polymorphisms and K-ras gene mutation in smoking non-small-cell lung cancerWei-Min Gao, Marjorie Romkes, Jill M Siegfried, et al.
Medical Physics|August 17, 2012
Illustration of the obstacles in computerized lung segmentation using examplesXin Meng, Yongqian Qiang, Shaocheng Zhu, et al.
Molecular Carcinogenesis|July 26, 2006
Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokersWei-Min Gao, Marjorie Romkes, Jill M Siegfried, et al.
Oncotarget|April 28, 2017
Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancerJill M Siegfried, Mariya Farooqui, Natalie J Rothenberger, et al.
Chest|May 12, 2004
Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lungJill M Siegfried, James D Luketich, Laura P Stabile, et al.
Pageof 12